hotspot -WSS

hotspot

author：entertainment 2025-09-28 01:37:17 - browse：5582

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： PBM reform efforts get punted in Congress

focus

WSS

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Venture capitalist Bob Kocher on the state of digital health

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

STAT readers on older presidents, polypills, Medicare, and more

NIH study of ME/CFS points to clear biological hallmarks

entertainment

hotspot

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Psychedelics group wrestles with new pharma identity

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Moonlake's readout produced a cash windfall. Risks remain

Alabama IVF ruling threatens families facing fatal genetic disease

Wildfire smoke exposes gaps in outdoor worker protections

Arc Institute generative AI designs new CRISPR systems

BioMarin wins approval for gene therapy to treat hemophilia A

PBM reform efforts get punted in Congress

explore

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Helping hospitals and community health centers plan for resilience

Criminal prosecution for violating HIPAA: an emerging threat

Addiction experts warn against a second 'war on drugs'

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

When prostate cancer spreads, where it goes matters

focus

focus

Wikipedia

Wikipedia